Development of a Prophylactic Onchocerciasis Vaccine

Period of Performance: 08/31/2016 - 08/30/2018

$442K

Phase 1 SBIR

Recipient Firm

Protein Advances, Inc.
Seattle, WA 98102
Principal Investigator

Abstract

To develop an onchocerciasis vaccine to be used for disease control and elimination.